 |
| RSH > Documents
> RSH Data Docs > 1.2
> 1.2.3 > 1.2.3.3 > Hattori
1994 References |
|
|
"Low Level Revision 1 1.2.3 1.2.3.3 |
Dr. Sadao Hattori, Vice President of
CRIEPI reports (BELLE 1994) on the benefits of radiation hormesis use, that: "Professor Sakamoto is using radiation hormesis to cure and to suppress the reappearance of cancer in the hospital of Tohoku University. For example, he applied 10 cGy twice weekly for several weeks successfully against liver cancer and lymphatic tumors. He is successfully applying whole body, or half body low level dose combined with local high dose irradiation to treat non-hodgkin’s lymphoma. The low survival rate of 36% in patients with non-hodgkin’s lymphoma after five years of the therapy improved to a 90% survival rate with a low dose treatment schema. Some analytical results demonstrate an increase of the ratio of the helper T cells to suppressor T cells." |
RSH > Documents
> RSH Data Docs > 1.2
> 1.2.3 > 1.2.3.3 > Hattori
1994
|
For more information please contact the RSH President Jim Muckerheide
For website problems please contact the Webmaster |